Search - tctmd.com

Displaying 61 - 80 of 134

Sort: Relevancy | Date

Presentation

Vorapaxar in Patients with Diabetes and Prior MI:Findings from the TRA 2ºP-TIMI 50 Trial

Presenter: M.A. Cavender

February 19, 2015

Presentation CADECI 2015

Retos actuales del tratamiento antihipertensivo: ¿Qué debemos saber para tratar al paciente hipertenso?

Presenter: Dr. Luis Alcocer

February 18, 2015

Presentation

5-Year Outcomes of PCI vs CABG in Patients  With Diabetes Mellitus

Presenter: Akira Marui

February 08, 2015

Presentation

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Presenter: K.K.W. Olesen

November 13, 2014

Presentation

Impact of Acute and Chronic Hyperglycemia on In-Hospital Outcomes of Patients With AMI

Presenter: M Fujino

October 20, 2014

Presentation

VerifyNow in DIabetes High On-Treatment Platelet Reactivity: Switching from Clopidogrel to Prasugrel

Presenter: J.M. Cubero

October 06, 2014

Presentation

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

Presenter: Laurent Feldman

October 06, 2014

Presentation

Progression to Overt or Silent CAD in Asymptomatic Patients with Diabetes at High Coronary Risk

Presenter: Michael J. Zellweger

September 25, 2014

Presentation TCT 2014

Thoughtful Insights

Presenter: Steven P. Marso

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Manish A. Parikh

September 17, 2014

Presentation TCT 2014

Case Conclusion: A Diabetic Patient with Double Vessel Coronary Artery Disease How Did I Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

Presentation TCT 2014

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

Presenter: George D. Dangas, Michael E. Farkouh, Usman Baber

September 16, 2014

Presentation TCT 2014

The Case for CABG in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, John D. Puskas

September 16, 2014

Presentation TCT 2014

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, Frederick Feit

September 16, 2014

Presentation TCT 2014

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Presenter: George D. Dangas, Michael E. Farkouh, David J. Maron

September 16, 2014

Presentation TCT 2014

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Presenter: George D. Dangas, Michael E. Farkouh, Manish A. Parikh

September 16, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Presenter: Milan Chag

September 16, 2014

Presentation TCT 2014

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Presenter: Hiroyoshi Yokoi

September 16, 2014

Presentation TCT 2014

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Presenter: Javaid Iqbal

September 16, 2014

Presentation TCT 2014

Case Presentation #1: The Diabetic Patient Needing Revascularization

Presenter: Alejandro Cherro, Liliana R. Grinfeld, Adolfo G López Campanher

September 13, 2014

Advertisement

Vorapaxar in Patients with Diabetes and Prior MI:Findings from the TRA 2ºP-TIMI 50 Trial

Retos actuales del tratamiento antihipertensivo: ¿Qué debemos saber para tratar al paciente hipertenso?

5-Year Outcomes of PCI vs CABG in Patients  With Diabetes Mellitus

Long-term Outcome of SES and ZES Implantation in Patients With and Without Diabetes

Impact of Acute and Chronic Hyperglycemia on In-Hospital Outcomes of Patients With AMI

VerifyNow in DIabetes High On-Treatment Platelet Reactivity: Switching from Clopidogrel to Prasugrel

Impact of Diabetes and Metabolic Syndrome on Acute and Chronic On-Clopidogrel Platelet Reactivity in Patients with Stable CAD Receiving DES

Progression to Overt or Silent CAD in Asymptomatic Patients with Diabetes at High Coronary Risk

Thoughtful Insights

Case Presentation

Case Conclusion: A Diabetic Patient with Double Vessel Coronary Artery Disease How Did I Treat?

Chronic Renal Failure: An Emerging Important Risk Modifier in Patients with Multivessel CAD with and without Diabetes?

The Case for CABG in Most Patients with Multivessel Disease with and without Diabetes

The Case for PCI in Most Patients with Multivessel Disease with and without Diabetes

The Case for Medical Therapy without Revascularization in Most Patients with and without Diabetes

Case Introduction: A Diabetic Patient with Double Vessel Coronary Artery Disease How Should We Treat?

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT___

Diabetic patients treated with Bioresorbable Vascular Scaffolds show good clinical outcomes at two-year follow-up: A pooled analysis from the ABSORB and SPIRIT trials

Case Presentation #1: The Diabetic Patient Needing Revascularization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content